President and CEO, Pharmaceutical Diagnostics segment at GE HealthCare
Appears in 1 story
Leading the division that will absorb Sofie Biosciences
GE HealthCare agreed to buy Sofie Biosciences, a U.S. manufacturer of radioactive imaging drugs, for $945 million in cash. The deal adds 15 manufacturing sites and 21 cyclotrons that produce F18-labeled tracers used in positron emission tomography (PET) scans.
Updated Yesterday
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
